PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate principal amount of senior secured notes due 2028 with a fixed interest rate of 3.375% and the issuance of EUR250m in aggregate principal amount of senior secured notes due 2029 with a fixed interest rate of 5%.

In parallel to these issuances, Biogroup has entered into a new senior facilities agreement in an aggregate principal amount of EUR1.721billion

Raising nearly EUR2.771b has enabled Biogroup to refinance its existing debt and optimize its financing structure.